I. HEALTH ASSESSMENT C. HEALTH STATUS 2. CHRONIC DISEASE

Similar documents
I. HEALTH ASSESSMENT B. SOCIOECONOMIC CHARACTERISTICS

Alabama s Rural and Urban Counties

Part 4 Burden of disease: DALYs

Selected Health Status Indicators DALLAS COUNTY. Jointly produced to assist those seeking to improve health care in rural Alabama

Stroke: A Public Health Issue

Denver County Births and Deaths 2013

Leading Causes of Death, by Race & Ethnicity

Connecticut Diabetes Statistics

Maryland Population POLICY ACADEMY STATE PROFILE. Maryland MARYLAND POPULATION (IN 1,000S) BY AGE GROUP

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Globally 12% of all deaths among adults aged 30 years and over were attributed to tobacco.

Public Health Annual Report Statistical Compendium

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

NURSING IN EGYPT. Age. Female. Male EGYPT DEMOGRAPHICS PROFILE AGENDA. Net migration rate: migrant(s)/1,000 population (2009 est.

Statistical Report on Health

Chapter 2: Health in Wales and the United Kingdom

Populations of Color in Minnesota

Life Expectancy and Deaths in Buckinghamshire

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work.

National Life Tables, United Kingdom:

Texas Diabetes Fact Sheet

11/26/2014 Page 1. LCWK9. Deaths, percent of total deaths, and death rates for the 15 leading causes of death: United States and each State, 2012

Massachusetts Population

New Jersey Population

5 Burden of disease and injury

Multimorbidity in patients with type 2 diabetes mellitus in the Basque Country (Spain)

in children less than one year old. It is commonly divided into two categories, neonatal

Ealing JSNA Chapter 19. How we Compare to Similar Authorities

The population with diabetes is less healthy than the population without it.

How long men live. MALE life expectancy at birth Newcastle compared to England and other Core Cities

Health, history and hard choices: Funding dilemmas in a fast-changing world

The Burden Of Diabetes And The Promise Of Biomedical Research

NCDs POLICY BRIEF - INDIA

CCG Outcomes Indicator Set: Emergency Admissions

Facts about Diabetes in Massachusetts

Improving General Practice a call to action Evidence pack. NHS England Analytical Service August 2013/14

THE TOP TEN CAUSES OF DEATH

Scottish Diabetes Survey

Kansas Behavioral Health Risk Bulletin

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

New Zealand mortality statistics: 1950 to 2010

Educational Attainment in the United States: 2015

Achieving Quality and Value in Chronic Care Management

of Diabetes in Delaware

Health Summary NHS East and North Hertfordshire Clinical Commissioning Group January 2013

Diabetes. African Americans were disproportionately impacted by diabetes. Table 1 Diabetes deaths by race/ethnicity CHRONIC DISEASES

The Health and Well-being of the Aboriginal Population in British Columbia

State Health Assessment Health Priority Status Report Update. June 29, 2015 Presented by UIC SPH and IDPH

Burke Rehabilitation Hospital 2014 Community Service Plan update

Part 3 Disease incidence, prevalence and disability

King County City Health Profile Vashon Island

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

APPLICATION FOR MEDICARE SUPPLEMENT COVERAGE

Golden Solution. Whole Life Insurance. American-Amicable Life Insurance Company of Texas

Florida Population POLICY ACADEMY STATE PROFILE. Florida FLORIDA POPULATION (IN 1,000S) AGE GROUP

Disability Living Allowance Reform. Equality Impact Assessment May 2012

JAMAICA. Recorded adult per capita consumption (age 15+) Last year abstainers

Smoking in the United States Workforce

HEALTH TRANSITION AND ECONOMIC GROWTH IN SRI LANKA LESSONS OF THE PAST AND EMERGING ISSUES

Health Indicators. Issue 2-September 2011

Exercise Answers. Exercise B 2. C 3. A 4. B 5. A

African Americans & Cardiovascular Diseases

Women in the Workforce

Hepatitis C Infections in Oregon September 2014

Final Expense Whole Life Insurance

The United American Final Expense Plan 400 Series

Against the Growing Burden of Disease. Kimberly Elmslie Director General, Centre for Chronic Disease Prevention

Indices of Morbidity and Mortality. Sukon Kanchanaraksa, PhD Johns Hopkins University

THE BURDEN OFTOBACCO IN ALABAMA

Closing the Gap Life Expectancy

Malmö Preventive Project. Cardiovascular Endpoints

CENTRAL STATES INDEMNITY CO. OF OMAHA Home Office: Omaha, NE Administration: P.O. Box Clearwater, Florida

1.14 Life expectancy at birth

Health Profile for St. Louis City

Health Disparities in New Orleans

Cardiovascular Endpoints

Snoring and Obstructive Sleep Apnea (updated 09/06)

Protecting and improving the nation s health. Alcohol treatment in England

Introduction. Methods

The 2014 Update of the Rural-Urban Chartbook

Research and Statistics Note

H ealth S tatus R eport

Healthy Ohio Community Profiles

Military Health System Conference

Report on the Burden of Chronic Diseases in Mississippi, 2014

America s Health Starts With Healthy Children: How Do States Compare?

Alcohol Units. A brief guide

Brief Research Report: Fountain House and Use of Healthcare Resources

Southern NSW Local Health District: Our Population s Health

Butler Memorial Hospital Community Health Needs Assessment 2013

Type 1 Diabetes ( Juvenile Diabetes)

Seniors. health. Report. A Peel Health Status Report

SUMMARY- REPORT on CAUSES of DEATH: in INDIA

Community Information Book Update October Social and Demographic Characteristics

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Health-care expenditure on cardiovascular diseases

inflammation of the pancreas and damage to the an increased risk of hypertension, stroke and Table 7.1: Classification of alcohol consumption

The Final Expense Life Insurance Handbook

Transcription:

HEALTH ASSESSMENT CHRONIC DISEASE I. HEALTH ASSESSMENT C. HEALTH STATUS 2. CHRONIC DISEASE WHAT IS THE HEALTH STATUS OF DELAWARE RESIDENTS IN TERMS OF CHRONIC DISEASE? Relative to benchmarks, Delaware residents have higher mortality rates of heart disease and diabetes, comparable rates of both chronic obstructive pulmonary disease and chronic liver disease, but slightly lower rates of cerebrovascular disease and kidney disorders. Cardiovascular mortality rates and disease prevalence are greater in Delaware relative to most benchmark communities and the national rate. Consistent with stakeholder beliefs, major cardiovascular disease is one of the leading causes of death for Delaware residents. Approximately 170 of every 100,000 persons living in Delaware died from cardiovascular diseases in 1997. Delaware residents die at slightly higher rates from major cardiovascular disease relative to most benchmark communities and the Delaware s heart disease mortality rate (138.3 deaths per 100,000 persons) was slightly higher than the national rate (130.4 deaths per 100,000 persons) and most neighboring states but 37 percent higher than Washington State. Similar to the national experience, females accounted for slightly more than half (51 percent) of all heart disease deaths in Delaware 1. Based on self reported disease from a survey, prevalence of ischemic heart disease in Delaware was substantially higher than the TECHNICAL NOTE Due to the small number of incidents of several chronic diseases (i.e., diabetes, COPD and liver disease), slight year-to-year changes can lead to substantial fluctuations in annual rates. Delaware adjusts for these fluctuations by calculating five-year average rates. The Lewin Group chose to use single year statistics instead of five-year averages in order to benchmark Delaware against other states. Most of the data presented in the Health Assessment are 1997 data from the National Center for Health Statistics. Although Delaware has published 1998 vital statistics data, The Lewin Group used 1997 data in order to compare Delaware to other states and the nation. national rate. The rate for Delaware residents was nearly triple the national estimated rate for individuals between 45 and 64 years and over double the national rate for individuals 65 years or older 2. 1 The five-year average mortality rate for heart disease in Delaware was 144.4. 2 The methodology used to determine prevalence of disease in the Delaware community is different from the methodology used to determine national prevalence. National prevalence estimates were obtained from the 1996 69

HEALTH ASSESSMENT CHRONIC DISEASE Hypertension prevalence estimates for Delaware residents are higher for every age group than the national prevalence estimates. For those over age 65, the prevalence is almost 50 percent, while the national estimate is 36 percent 2. Delaware residents have higher rates of diabetes and die more often from the disease than residents in most comparison communities. The estimated prevalence of diabetes in Delaware was double the national rate for individuals less than 45 years and over 30 percent higher than the national rate for Delaware residents older than 45 years 2. Reflecting community stakeholder concerns, the diabetes mortality rate in Delaware is higher than the and most benchmark communities. In 1997, the diabetes mortality rate in Delaware (16.1 deaths per 100,000 persons) was higher than those of all comparison communities except for Maryland 3. A survey of Delaware residents conducted by The Lewin Group in 2000 indicated that the vast majority of study respondents (94 percent) with diabetes were taking medication or insulin for this disease. However, only 80 percent of study respondents reported annual eye exams compared to the optimal performance level of 100 percent. Performance also was lower on standards for foot care. Only 57 percent of residents reported being asked by their doctor about foot care during the year. The chronic obstructive pulmonary disease (COPD) mortality rate in Delaware is comparable to the, slightly higher than neighboring states, but below Washington State and consensus-based standards. In 1997, Delaware residents died from COPD at a rate of 21.2 deaths per 100,000 persons. Delaware s COPD mortality rate is comparable to the national rate and higher than most comparison states except Washington State 4. Delaware met the Healthy People 2000 objective of reducing the COPD death rate to no more than 25.0 deaths per 100,000 persons. National Health Interview Survey, which is a multistage probability sample conducted through in-home interviews by the Bureau of the Census. Delaware prevalence estimates were obtained from a self-reported mail survey in 2000 conducted by The Lewin Group. 3 The five-year average mortality rate for diabetes in Delaware was 14.2. 4 The five-year average mortality rate for COPD in Delaware was 21.4. 70

HEALTH ASSESSMENT CHRONIC DISEASE The death rate for chronic liver disease and cirrhosis in Delaware is within the range of state and national benchmarks. In 1997, the chronic liver disease and cirrhosis death rate for Delaware (6.5 deaths per 100,000 persons) was lower than in the and fell within the range of comparison states rates 5. Cerebrovascular disease mortality in Delaware is lower than the majority of benchmarks, but higher than consensus-based standards. In 1997, the cerebrovascular disease mortality rate in the Delaware (22.2 deaths per 100,000 persons) was 14 percent lower than the national rate (25.9 deaths per 100,000 persons) and those of most comparison communities 6. Though lower than rates in most benchmark communities, Delaware s cerebrovascular disease mortality rate was 11 percent higher than the Healthy People 2000 objective of 20 deaths per 100,000 persons. Comparable to the national rate, women accounted for 59 percent of cerebrovascular disease deaths. Delaware s mortality rate due to kidney disorders (e.g., nephritis, nephrotic syndrome and nephrosis) falls within the range of benchmarks. In 1997, Delaware experienced 4.9 kidney disorder-related deaths per 100,000 persons. Although 11 percent higher than the mortality rate and 113 percent higher than that of Washington State, Delaware s mortality due to kidney disorders was four percent to 17 percent lower than other comparison states 7. 5 The five-year average mortality rate for chronic liver disease and cirrhosis in Delaware was 7.4. 6 The five-year average mortality rate for cerebrovascular disease in Delaware was 22.6. 7 The five-year mortality rate for kidney disease in Delaware was 5.7. 71

Exhibit I-C-12: Chronic disease mortality statistics indicate that Delaware s experience is more favorable for cerebrovascular disease but less favorable for heart disease and diabetes compared to benchmarks. Indicators Chronic Disease Major Cardiovascular Disease Heart Disease Cerebrovascular Disease Diabetes Mellitus Chronic Obstructive Pulmonary Disease Chronic Liver Disease Kidney Disorders: Nephristis, Nephrotic Syndrome, and Nephrosis Performance Relative to s: More Favorable Comparable Less Favorable 72

Exhibit I-C-13: In 1997, Delaware s diabetes rate was higher than the national average, while its rates of cerebrovascular disease and chronic liver disease were lower. Death Rates per 100,000 Persons (a) 1997 Delaware Overall Difference in Rates Heart Disease 138.3 130.4 6% Cerebrovascular Disease 22.2 25.9 (14%) Chronic Obstructive Pulmonary Disease and Allied Conditions 21.2 21.1 0% Diabetes Mellitus 16.1 13.6 18% Chronic Liver Disease and Cirrhosis 6.5 7.3 (11%) 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. (a) Death rates are age-adjusted to the 1940 national population. 73

Exhibit I-C-14: Major cardiovascular disease is one of the leading causes of death in Delaware, and Delaware residents died from cardiovascular disease at a comparable rate to most benchmarks. Major Cardiovascular Disease Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware 169.3 166.2 2% Maryland 162.4 4% Comparison Communities New Jersey 155.0 9% Pennsylvania 172.3 (2%) Washington State 135.8 25% 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. (a) Death rates are age-adjusted to the 1940 national population. 74

Exhibit I-C-15: Delaware s heart disease mortality rate was comparable to the but slightly higher than most state benchmarks. Heart Disease Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware(b) 138.3 130.4 6% Maryland 128.5 8% Comparison Communities New Jersey 124.7 11% Pennsylvania 138.7 0% Washington State 100.8 37% 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. (a) Death rates are age-adjusted to the 1940 national population. (b) Although Delaware uses five-year averages to compensate for small sample size, one-year rates are used here so that Delaware can be compared to benchmarks. The five-year average mortality rate for heart disease in Delaware was 144.4. 75

Exhibit I-C-16: Similar to the national experience, heart disease deaths were nearly evenly split between men and women in Delaware. Proportion of Deaths by Sex Heart Disease 1997 Males Females Delaware 49% 51% 49% 51% 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. 76

Exhibit I-C-17: Delaware s cerebrovascular death rate was lower than most benchmarks but it was 11 percent higher than the Healthy People 2000 Objective. Cerebrovascular Disease Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware(b) 22.2 25.9 (14%) Maryland 25.4 (13%) Comparison Communities New Jersey 21.3 4% Pennsylvania 24.5 (9%) Washington State 25.5 (13%) Consensusbased Standard Healthy People 2000 Objective(c) 20.0 11% 1-6) 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software; 7) Healthy People 2000 Objectives. (a) Death rates are age-adjusted to the 1940 national population. (b) Although Delaware uses five-year averages to compensate for small sample size, one-year rates are used here so that Delaware can be compared to benchmarks. The five-year average mortality rate for cerebrovascular disease in Delaware was 22.6. (c) Healthy People 2000 objective to reduce stroke deaths. 77

Exhibit I-C-18: In 1997, females accounted for almost 60 percent of all cerebrovascular disease deaths in Delaware. This proportion mirrors that of the national experience. Proportion of Deaths by Sex Cerebrovascular Disease 1997 Males Females Delaware 41% 59% 39% 61% 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. 78

Exhibit I-C-19: Delaware s estimated rates of hypertension and ischemic heart disease are higher than the national estimated rate for these conditions. Estimated Prevalence of Cardiovascular Disease Delaware and Condition Hypertension Delaware 2000 1996 Percent Over < 45 Years of Age 9.0% 3.0% 200% 45 64 Years of Age 27.9% 21.4% 30% > 65 Years of Age 47.6% 36.4% 31% Ischemic Heart Disease < 45 Years of Age 4.5% 0.3% 1400% 45 64 Years of Age 14.1% 5.2% 171% > 65 Years of Age 33.1% 14.1% 135% 1) The Lewin Group, Inc., Delaware Community Assessment: Health Assessment Survey, 2000; 2) 1996 National Health Interview Survey. Delaware prevalence estimates do not include respondents for whom age could not be calculated because birth date was missing. Eight patients with no age reported having ischemic heart disease. 79

Exhibit I-C-20: In 1997, Delaware experienced a higher diabetes mortality rate compared to the and two of the four comparison states. Diabetes Mellitus Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware(b) 16.1 13.6 18% Maryland 17.0 (5%) Comparison Communities New Jersey 15.6 3% Pennsylvania 14.1 14% Washington State 12.1 33% 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. (a) Death rates are age-adjusted to the 1940 national population. (b) Although Delaware uses five-year averages to compensate for small sample size, one-year rates are used here so that Delaware can be compared to benchmarks. The five-year average mortality rate for diabetes in Delaware was 14.2. 80

Exhibit I-C-21: In 1997, Delaware s residents experienced a COPD mortality rate that fell within the range of benchmarks. Chronic Obstructive Pulmonary Diseases and Allied Conditions Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware(b) 21.2 21.1 0% Maryland 20.0 6% New Jersey 16.4 29% Comparison Communities Pennsylvania 18.6 14% Washington State 23.3 (9%) Consensusbased Standard Healthy People 2000 Objective(c) 25.0 (15%) 1-6) 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software; 7) Healthy People 2000 Objectives. (a) Death rates are age-adjusted to the 1940 national population. (b) Although Delaware uses five-year averages to compensate for small sample size, one-year rates are used here so that Delaware can be compared to benchmarks. The five-year average mortality rate for COPD in Delaware was 21.4. (c) Healthy People 2000 objective to slow the rising COPD death rate to no more than 25.0 deaths per 100,000 persons. 81

Exhibit I-C-22: Delaware residents experienced a comparable rate of chronic liver disease and cirrhosis death rates compared to benchmarks. Chronic Liver Disease and Cirrhosis Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware(b) 6.5 7.3 (11%) Maryland 6.4 2% Comparison Communities New Jersey 6.8 (4%) Pennsylvania 5.9 10% Washington State 7.2 (10%) 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. (a) Death rates are age-adjusted to the 1940 national population. (b) Although Delaware uses five-year averages to compensate for small sample size, one-year rates are used here so that Delaware can be compared to benchmarks. The five-year average mortality rate for chronic liver disease and cirrhosis in Delaware was 7.4. 82

Exhibit I-C-23: Delaware s kidney disorder mortality rate fell within the range of benchmarks. Kidney Disorders: Nephritis, Nephrotic Syndrome, and Nephrosis Deaths per 100,000 Persons (a) 1997 % Over/(Under) Delaware(b) 4.9 4.4 11% Maryland 5.1 (4%) Comparison Communities New Jersey 5.9 (17%) Pennsylvania 5.9 (17%) Washington State 2.3 113% 1997 data, National Center for Health Statistics; CDC, CDC Wonder Data Extraction Software. (a) Death rates are age-adjusted to the 1940 national population. (b) Although Delaware uses five-year averages to compensate for small sample size, one-year rates are used here so that Delaware can be compared to benchmarks. The five-year average mortality rate for kidney disease in Delaware was 5.7. 83